Cargando…
Lasting shift in the gut microbiota in patients with acute myeloid leukemia
Previous studies have shown that the gut microbiota of patients with acute myeloid leukemia (AML) is disrupted during induction chemotherapy; however, the durability of microbiota changes is unknown. This is an important knowledge gap, because reduced microbiota diversity at the time of stem cell tr...
Autores principales: | Rashidi, Armin, Ebadi, Maryam, Rehman, Tauseef Ur, Elhusseini, Heba, Halaweish, Hossam Fathi, Kaiser, Thomas, Holtan, Shernan G., Khoruts, Alexander, Weisdorf, Daniel J., Staley, Christopher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198907/ https://www.ncbi.nlm.nih.gov/pubmed/35192686 http://dx.doi.org/10.1182/bloodadvances.2021006783 |
Ejemplares similares
-
Compilation of longitudinal gut microbiome, serum metabolome, and clinical data in acute myeloid leukemia
por: Rashidi, Armin, et al.
Publicado: (2022) -
Loss of microbiota-derived protective metabolites after neutropenic fever
por: Rashidi, Armin, et al.
Publicado: (2022) -
Gut microbiota response to antibiotics is personalized and depends on baseline microbiota
por: Rashidi, Armin, et al.
Publicado: (2021) -
Effect of COVID-19 precautions on the gut microbiota and nosocomial infections
por: Rashidi, Armin, et al.
Publicado: (2021) -
Altered microbiota-host metabolic cross talk preceding neutropenic fever in patients with acute leukemia
por: Rashidi, Armin, et al.
Publicado: (2021)